Related Experiment Video
Updated: May 31, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes
Matthew E Falagas1, Drosos E Karageorgopoulos, Patrice Nordmann
1Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece.
Abstract:
Enterobacteriaceae that produce serine carbapenemases or metallo-β-lactamases, such as KPC, OXA-48, VIM or NDM, respectively, are spreading mostly as nosocomial pathogens worldwide. Such strains are typically resistant to most if not all available antimicrobials. Specific relevant clinical data are scarce to guide the determination of the most appropriate treatment options. Data on antimicrobial susceptibility, resistance development, synergy, pharmacokinetic and pharmacodynamic parameters of the candidate regimens, as well as the experience from the treatment of infections with nonfermenting Gram-negative pathogens, can aid in this regard. Colistin and tigecycline are most likely to be active in vitro against Enterobacteriaceae producing carbapenem-hydrolyzing β-lactamases, but resistance development is of concern. Individual members of the aminoglycoside class can also be active in vitro, while carbapenems or aztreonam (specifically for metallo-β-lactamase producers) can have low minimum inhibitory concentrations. Current data do not reliably support the use of these agents as monotherapy for systemic infections. Several expanded-spectrum cephalosporins, such as ceftazidime, may be active against OXA-48 type producers. Fosfomycin might be useful as a last-resort option as part of combination regimens. Combination antimicrobial therapy with agents exhibiting synergy might also be of benefit, until novel effective agents could become clinically available.
Insights
Treatment options for carbapenemase-producing Enterobacteriaceae are limited. Colistin, tigecycline, and combination therapies show potential, but resistance and lack of clinical data require careful consideration for effective antimicrobial strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Carbapenemase-producing Enterobacteriaceae (CPE) are emerging global nosocomial pathogens.
- These strains exhibit resistance to most available antimicrobials, complicating treatment.
- Clinical data guiding optimal therapy for CPE infections are scarce.
Purpose of the Study:
- To review current antimicrobial options for treating infections caused by carbapenemase-producing Enterobacteriaceae.
- To evaluate the in vitro activity, resistance development, and potential clinical utility of various antimicrobial agents.
- To discuss the role of combination therapy and emerging treatment strategies.
Main Methods:
- Literature review of antimicrobial susceptibility data.
- Analysis of pharmacokinetic/pharmacodynamic parameters.
- Evaluation of synergy and resistance development.
- Consideration of clinical experience with similar pathogens.
Main Results:
- Colistin and tigecycline demonstrate in vitro activity but raise concerns about resistance.
- Aminoglycosides, carbapenems, and aztreonam (for MBL producers) show variable activity.
- Expanded-spectrum cephalosporins (e.g., ceftazidime) may be active against OXA-48 producers.
- Fosfomycin may serve as a last-resort option in combination regimens.
Conclusions:
- Monotherapy with current agents is not reliably supported for systemic CPE infections.
- Combination antimicrobial therapy with synergistic agents may offer benefits.
- Further research and novel agents are needed for effective treatment of CPE infections.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care